Wakamoto Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Wakamoto Pharmaceutical Co. Ltd.
Nomura Asset TOPIX ETF Fund (1306)
375,700
1.08%
5,900
0%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
184,400
0.53%
3,400
0%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
169,500
0.49%
0
0%
08/20/2018
DFA Japanese Small Company Series
107,000
0.31%
0
0.01%
01/31/2018
Mitsubishi UFJ MAXIS TOPIX ETF (1348)
49,400
0.14%
1,500
0%
07/31/2018
Nikko Asset Low Price Stocks Fund
16,999
0.05%
-1
0.08%
05/29/2017
Mitsubishi UFJ Asset Management TOPIX Mother Fund
16,000
0.05%
0
0%
03/27/2017
Nomura Asset Domestic Equity Mother Fund
16,000
0.05%
0
0%
02/19/2018
DIAM (Japan) Domestic Equity Passive Fund Mother Fund
14,000
0.04%
0
0%
04/11/2018
SMTAM Japanese Equity Mother Fund
11,000
0.03%
-1,000
0%
12/11/2017
| Address |
2-2-2 Nihonbashi Hon-cho
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.wakamoto-pharm.co.jp |
| Updated |
07/08/2019 |
| Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and non-prescription drugs. Its operations are carried out through the following segments: Medicine, Non-Prescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs. |
